Your browser doesn't support javascript.
loading
Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
Tang, Patrick Chun Hean; Ng, Wern Hann; King, Nicholas J C; Mahalingam, Suresh.
Afiliación
  • Tang PCH; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia.
  • Ng WH; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia.
  • King NJC; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia.
  • Mahalingam S; The Discipline of Pathology and Bosch Institute, School of Medical Sciences, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
PLoS Pathog ; 18(9): e1010821, 2022 09.
Article en En | MEDLINE | ID: mdl-36129963
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2022 Tipo del documento: Article País de afiliación: Australia